Variant report
Variant | esv3334479 |
---|---|
Chromosome Location | chr2:116373732-116376030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192051342 | chr2:116373770-116373771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550596057 | chr2:116373799-116373800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543376588 | chr2:116373848-116373849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4849413 | chr2:116373882-116373883 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs532411752 | chr2:116373917-116373918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10496499 | chr2:116373937-116373938 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs184129233 | chr2:116373941-116373942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528182372 | chr2:116373945-116373946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551133835 | chr2:116373952-116373953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548616812 | chr2:116373961-116373962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4848394 | chr2:116373968-116373969 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs144024336 | chr2:116374008-116374009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550073051 | chr2:116374041-116374042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570036790 | chr2:116374062-116374063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538900636 | chr2:116374080-116374081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567744016 | chr2:116374089-116374090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76750232 | chr2:116374100-116374101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188632945 | chr2:116374176-116374177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534855168 | chr2:116374230-116374231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555022992 | chr2:116374253-116374254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574578002 | chr2:116374270-116374271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537263930 | chr2:116374281-116374282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146456328 | chr2:116374285-116374286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577211708 | chr2:116374337-116374338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114750860 | chr2:116374349-116374350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200912885 | chr2:116374374-116374375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559430210 | chr2:116374431-116374432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192725414 | chr2:116374472-116374473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541595409 | chr2:116374561-116374562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373109703 | chr2:116374562-116374563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371734147 | chr2:116374564-116374565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:116371800-116373800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr2:116373200-116374600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:116373600-116374600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:116373800-116374400 | Enhancers | Cortex derived primary cultured neurospheres | brain |